Kiromic BioPharma, Inc.
KRBPQ
$0.0615
-$0.083-57.44%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.13% | 12.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.60% | 3.94% | |||
| Operating Income | 13.60% | -3.94% | |||
| Income Before Tax | 12.70% | -8.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.70% | -8.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.70% | -8.94% | |||
| EBIT | 13.60% | -3.94% | |||
| EBITDA | 15.10% | -4.40% | |||
| EPS Basic | 314.73% | -10.42% | |||
| Normalized Basic EPS | 12.66% | -6.13% | |||
| EPS Diluted | 314.73% | -10.42% | |||
| Normalized Diluted EPS | 12.66% | -6.13% | |||
| Average Basic Shares Outstanding | -0.05% | 2.64% | |||
| Average Diluted Shares Outstanding | -0.05% | 2.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||